Carl L. Gordon, a director at Electra Therapeutics, Inc., buys $3.61M of stock

Carl L. Gordon bought $3.61 million of Electra Therapeutics, Inc. (ETRA) stock between Nov 3 and Nov 5, according to an SEC filing. The director paid an average of $7.63 for 472,571 shares.

The purchase was made in the open market, not through an award, an option exercise or a plan. With this purchase the insider holds 7,357,741 shares, 6.9% more than before.

The trade was reported within two business days, as Section 16 requires.

The numbers below are taken from the Form 4 as filed with the SEC.

The purchase

Company	Electra Therapeutics, Inc. (ETRA)
Insider	Carl L. Gordon
Role	Director
Transaction	Open-market purchase (code P)
Shares	472,571
Average price	$7.63
Value	$3,605,117
Trade dates	Nov 3 to Nov 5, 2026
Filed with the SEC	Nov 5, 2026, 5:47 PM ET
Shares held after	7,357,741
Ownership	Indirect
Rule 10b5-1 plan	Not marked in the filing

See more details on this insider purchase

View the Form 4 on SEC.gov

See all the latest insider trades · Follow ETRA for the next insider trade

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.